Lukas Biomedical Inc. (6814)
Market Closed
11 Aug, 05:30
TWSE 
NT$
24. 10
+0.05
+0.2079%
NT$
- Market Cap
- P/E Ratio
60% Div Yield
23,028 Volume
- Eps
NT$ 24.05
Previous Close Want to track 6814 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lukas Biomedical Inc. (6814) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.13B
Trailing P/E (ttm) -11.8
Forward P/E -
PEG ratio -0.83
Price/Sales (ttm) 5.65
Price/Book (mrq) 4.22
Enterprise Value/Revenue 6.32
Enterprise Value/EBITDA -18.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 11.04K
Average volume (90 days) 19.22K
Price summary
52-Week low 21
52-Week high 32.5
Beta -
50-Day moving average 24.6
200-Day moving average 25.71
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 26 Feb 2026
Ex-Dividend Date 26 Feb 2026
Last split factor 1,033:1,000
Last split Date 30 Aug 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.48%
Operating margin -0.45%
Operational effectiveness
Return on assets -0.2%
Return on equity -0.33%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.29
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.83
Total debt (mrq) -
Total Debt/Equity (mrq) 0.65
Current ratio (mrq) 0.8%
Book value per share (mrq) 5.74
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
